BioSig Technologies Inc (OQ:BSGM)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEC
Company Contact
Address: 55 Greens Farms Road
WESTPORT CT 06880
Tel: N/A
Website: https://www.biosig.com
IR: See website
<
Key People
Frederick D. Hrkac
President, Principal Executive Officer, Director
   
Business Overview
BioSig Technologies, Inc. is a medical technology company. The Company is focused on commercializing an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Its product PURE EP System is a non-invasive class II device consisting of a combination of hardware and software designed to provide signal clarity and precision for real-time visualization of intracardiac signals, paving the way for personalized patient care. PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated with signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.
Financial Overview
For the fiscal year ended 31 December 2023, BioSig Technologies Inc revenues decreased 94% to $18K. Net loss applicable to common stockholders increased 7% to $29.1M. Revenues reflect Product decrease from $254K to $0K, Service decrease of 44% to $18K. Higher net loss reflects BioSig Technologies Inc segment loss increase of 10% to $29.3M, BioSig AI sciences Inc segment loss increase of 11% to $745K.
Employees: 4 as of Apr 15, 2024
Reporting Currency: U.S. Dollars
Enterprise value: $17.23M as of Dec 31, 2023
Annual revenue (TTM): $0.02M as of Dec 31, 2023
EBITDA (TTM): -$28.15M as of Dec 31, 2023
Net annual income (TTM): -$29.05M as of Dec 31, 2023
Free cash flow (TTM): -$17.50M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 11,198,174 as of Apr 15, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.